top of page


Integrating equitable access conditions into antimicrobial R&D incentive mechanisms
During the 2024 UN High-Level Meeting on Antimicrobial Resistance (AMR), stakeholders set an ambitious goal to achieve a 10% reduction in...
Aanika Dalal
Jun 211 min read


Why the EU’s Antibiotic Revenue Guarantee Scheme Stalled – and how to fix it
Bringing life-saving antibiotics to market is a paradox: doctors depend on them, yet are trained to use them sparingly. This creates a...

David McKinney
Mar 275 min read


Updating our Pull Incentives Cost-Benefit Analysis
As part of the EcoAMR series  the Center for Global Development (CGD) recently published a modelling study on the global direct inpatient...

ARMoR
Feb 242 min read
bottom of page